Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Susceptibility-Driven Sequential Therapy for Refractory H. Pylori
NCT01032655Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin, metronidazole, clarithromycin, levofloxacin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Apr 2009; status: completed.
02
Drugs
esomeprazoleamoxicillinmetronidazoleclarithromycinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01032655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032655.